Literature DB >> 12119045

A non-radioactive method for the assay of many serine/threonine-specific protein kinases.

Heike Ross1, Christopher G Armstrong, Philip Cohen.   

Abstract

The generation of drugs that modulate the activities of particular protein kinases has become a prime focus of the pharmaceutical and biotechnology industry. Consequently, improved methods for the development of high-throughput screening formats for these enzymes is a high priority. In the present study, we have designed three generic peptide substrates that can be used to assay a diverse range of protein kinases. These peptides share a common seven-residue epitope that includes the site of phosphorylation, and against which we have generated a phospho-specific antibody. Thus a large number of serine/threonine-specific protein kinases can be screened using a simple non-radioactive format.

Mesh:

Substances:

Year:  2002        PMID: 12119045      PMCID: PMC1222845          DOI: 10.1042/BJ20020786

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  11 in total

Review 1.  Protein kinases--the major drug targets of the twenty-first century?

Authors:  Philip Cohen
Journal:  Nat Rev Drug Discov       Date:  2002-04       Impact factor: 84.694

2.  Specificity and mechanism of action of some commonly used protein kinase inhibitors.

Authors:  S P Davies; H Reddy; M Caivano; P Cohen
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

Review 3.  How do protein kinases recognize their substrates?

Authors:  L A Pinna; M Ruzzene
Journal:  Biochim Biophys Acta       Date:  1996-12-12

4.  Phosphate groups as substrate determinants for casein kinase I action.

Authors:  H Flotow; P R Graves; A Q Wang; C J Fiol; R W Roeske; P J Roach
Journal:  J Biol Chem       Date:  1990-08-25       Impact factor: 5.157

5.  Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2.

Authors:  T Kobayashi; P Cohen
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

6.  Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes.

Authors:  J Liu; J D Farmer; W S Lane; J Friedman; I Weissman; S L Schreiber
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

Review 7.  From oncogene to drug: development of small molecule tyrosine kinase inhibitors as anti-tumor and anti-angiogenic agents.

Authors:  M J Morin
Journal:  Oncogene       Date:  2000-12-27       Impact factor: 9.867

8.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B.

Authors:  D A Cross; D R Alessi; P Cohen; M Andjelkovich; B A Hemmings
Journal:  Nature       Date:  1995 Dec 21-28       Impact factor: 49.962

9.  Comparison of the specificities of p70 S6 kinase and MAPKAP kinase-1 identifies a relatively specific substrate for p70 S6 kinase: the N-terminal kinase domain of MAPKAP kinase-1 is essential for peptide phosphorylation.

Authors:  I A Leighton; K N Dalby; F B Caudwell; P T Cohen; P Cohen
Journal:  FEBS Lett       Date:  1995-11-20       Impact factor: 4.124

10.  A mammalian protein targeted by G1-arresting rapamycin-receptor complex.

Authors:  E J Brown; M W Albers; T B Shin; K Ichikawa; C T Keith; W S Lane; S L Schreiber
Journal:  Nature       Date:  1994-06-30       Impact factor: 49.962

View more
  10 in total

1.  Investigating the regulation of brain-specific kinases 1 and 2 by phosphorylation.

Authors:  Nicola J Bright; David Carling; Claire Thornton
Journal:  J Biol Chem       Date:  2008-03-13       Impact factor: 5.157

2.  Measuring and interpreting the selectivity of protein kinase inhibitors.

Authors:  Lynette A Smyth; Ian Collins
Journal:  J Chem Biol       Date:  2009-06-06

3.  Assaying Protein Kinase Activity with Radiolabeled ATP.

Authors:  Aroon S Karra; Steve Stippec; Melanie H Cobb
Journal:  J Vis Exp       Date:  2017-05-26       Impact factor: 1.355

4.  Mass-tag technology responding to intracellular signals as a novel assay system for the diagnosis of tumor.

Authors:  Jeong-Hun Kang; Yoshiki Katayama; Aishan Han; Shuhei Shigaki; Jun Oishi; Kenji Kawamura; Riki Toita; Xiao Ming Han; Takeshi Mori; Takuro Niidome
Journal:  J Am Soc Mass Spectrom       Date:  2006-10-13       Impact factor: 3.109

5.  Fluorescence polarization assays in small molecule screening.

Authors:  Wendy A Lea; Anton Simeonov
Journal:  Expert Opin Drug Discov       Date:  2011-01       Impact factor: 6.098

6.  LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1.

Authors:  Jose M Lizcano; Olga Göransson; Rachel Toth; Maria Deak; Nick A Morrice; Jérôme Boudeau; Simon A Hawley; Lina Udd; Tomi P Mäkelä; D Grahame Hardie; Dario R Alessi
Journal:  EMBO J       Date:  2004-02-19       Impact factor: 11.598

7.  Development of a sensitive non-radioactive protein kinase assay and its application for detecting DYRK activity in Xenopus laevis oocytes.

Authors:  Eva Lilienthal; Katharina Kolanowski; Walter Becker
Journal:  BMC Biochem       Date:  2010-05-20       Impact factor: 4.059

8.  Nuclear DBF-2-related kinases are essential regulators of cytokinesis in bloodstream stage Trypanosoma brucei.

Authors:  Jiangtao Ma; Corinna Benz; Raffaella Grimaldi; Christopher Stockdale; Paul Wyatt; Julie Frearson; Tansy C Hammarton
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

9.  Cellular Ser/Thr-kinase assays using generic peptide substrates.

Authors:  Deanna G Adams; Yu Wang; Puiying A Mak; Jason Chyba; Orzala Shalizi; Jason Matzen; Paul Anderson; Tim R Smith; Michael Garcia; Genevieve L Welch; Emmanuel J Claret; Michel Fink; Anthony P Orth; Jeremy S Caldwell; Achim Brinker
Journal:  Curr Chem Genomics       Date:  2008-05-23

10.  Zn(II)-Coordinated Quantum Dot-FRET Nanosensors for the Detection of Protein Kinase Activity.

Authors:  Butaek Lim; Ji-In Park; Kyung Jin Lee; Jin-Won Lee; Tae-Wuk Kim; Young-Pil Kim
Journal:  Sensors (Basel)       Date:  2015-07-23       Impact factor: 3.576

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.